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Annual mass examinations in an area where the mortality rate due to 
liver disease is very high in Nagasaki Prefecture, Japan, have been 
done between 1984 and 1992 in order to evaluate the prevalence of 
chronic hepatitis B and C virus infection. The positivity rate for 
hepatitis B surface antigen (HBsAg) was 4.2%, whereas the positivity 
rate for anti-hepatitis C virus antibody (anti-HCV) was 9.5% as a 
whole and 7.2% with exclusion of the anti-HCV-positive inhabitants 
receiving blood transfusion. When the positivity rates for these 
markers were analyzed by year of birth, the positivity rate for HBsAg 
reached a peak (8.4%) in inhabitants born during 1941-45, and 
thereafter decreased. The positivity rates for anti-HCV, even when 
the anti-HCV-positive inhabitants receiving blood transfusion were 
excluded, were more than 7% in inhabitants born in 1935 and before, 
and thereafter followed by a decreasing trend as evidenced by the fact 
that none of inhabitants born in 1951 and after was 
anti-HCV-positive. 
These results suggest that the positivity rates for both of HBsAg and 
anti-HCV in inhabitants born in 1946 and after steadily decreace in 
Kami-Goto-town, where the positivity rates for these markers are, at 
present, very high.
Methods 
Kami-Goto-town is in the north area of Goto Islands (Fig. 
1). Most of the 9,000 inhabitants are engaged in fishing or 
agriculture. From death certificates, the mortality rate due 
to liver disease, especially hepatocellular carcinoma, is 
approximately 30 per 100,000 population in the last 10 
years.') Between 1984 and 1992, annual mass examinations 
in inhabitants aged 40 years old or more in men and 30 
years old or more in women have been done in this area. 
During the period, 2061 inhabitants were tested for HBsAg; 
652 were men and 1409 were women. In addition, 1325 
inhabitants who received annual mass examinations during 
1991-92 were also tested for anti-HCV antibody (anti-
HCV). There were 360 men and 965 women aged 40 to 81 
and 30 to 84 years old, respectively.
Introdution 
Liver cirrhosis is common in Nagasaki Prefecture, Japan, 
where the mortality rate due to liver disorders is especially 
high in Kami-Goto-town in the Goto Islands.'' Previous 
epidemiological studies demonstrated that chronic hepatitis 
B virus (HBV) infections were common in the Goto Is-
lands, and they were closely related to liver cirrhosis and 
hepatocellular carcinoma.",') In Japan, the HBV carrier 
rate currently decreased, but the incidence of liver cirrhosis 
and hepatocellular carcinoma steadily increased in the last 
10 years." 
 The recent cloning of the hepatitis C virus (HCV) ge-
nome and the availability of specific assays allowed to 
study the prevalence of HCV infection in patients with 
chronic liver diseases"') and showed that more than 70% of 
hepatitis B surface antigen (HBsAg)-negative patients with 
chronic hepatitis or liver cirrhosis were associated with 
chronic HCV infection in Japan.') 
 In the present study, the prevalence of chronic HBV and 
HCV infection was analyzed in inhabitants in Kami-
Goto-town, Nagasaki Prefecture, Japan.
Fig. 1. Location of Kami-Goto-town
 HBsAg was measured by reverse passive hemagglu-
tination method and anti-HCV (2nd generation) by 
enzyme-linked immunosorbent assay using a commercially 
available kit (Chiron Co, California, USA). 
 Statistical analyses were carried out using the chi-square 
test. P values < 0.05 were considered statistically signif-
icant.
Results 
HBsAg carrier rates 
Among 2061 inhabitants, 86 (4.2%) were positive for 
HBsAg (Table 1). The positivity rates for HBsAg in men 
and women were 4.6% and 4.0%, respectively. The differ-
ence was not significant (P > 0.5). When the HBsAg carrier 
rates were analyzed by year of birth, the rate reached a 
peak (8.4%) in inhabitants born during 1941-45, and there-
after decreased to 3.8% in inhabitants born during 1956-60 
(Fig. 1).
Table 1. The Positivity Rate for HBsAg in Inhabitants
                     Inhabitants tested (n = 2061) 
                  HBsAg (+) HBsAg (-)
No. of inhabitants 86 1975 
Sex ratio (M/F) 30/S6 622/1353 
Age (years old) 41-82 30-88
       Fig. 2. HBsAg Carrier Rate by Year of Birth 
The number of subjects tested for HBsAg is indicated below the 
horizontal line.
Anti-HCV positivity rates 
Of 1325 inhabitants tested for anti-HCV, 122 (9.2%) were 
anti-HCV-positive (Table 2). The positivity rate for anti-
HCV in men was slightly higher than that in women 
(12.2% vs. 8.1%, P < 0.05). Among the 122 anti-
HCV-positive inhabitants, 29 (23.8%) received blood trans-
fusion 7 to 42 years before examination; seven were men 
and 22 were women. Thus, the positivity rate for anti-HCV 
was 7.2% when these 29 inhabitants receiving blood trans-
fusion were excluded. To study changes in the prevalence 
of HCV infection which was not caused by blood trans-
fusion, the positivity rate for anti-HCV in inhabitants was 
analyzed by year of birth with exclusion of those who were 
anti-HCV-positive after receiving blood transfusion (Fig. 
2). The positivity rates for anti-HCV in inhabitants born in 
1935 and before were more than 7%; in contrast, the 
positivity rates in inhabitants born during 1936-50 ranged 
from 3 to 5%, and none of inhabitants born in 1951 and 
after was anti-HCV-positive.
Table 2. The Positivity Rate for Anti-HCV in Inhabitants
     Fig. 3. Anti-HCV Positivity Rate by Year of Birth 
The number of subjects tested for anti-HCV excluding anti-
HCV-positive inhabitants receiving blood transfusion is indicated 
below the horizontal line.
                         Inhabitants tested (n = 1325) 
                        anti-HCV (+) anti-HCV (-)
No. of inhabitants 122 1203 
Sex ratio (M/F) 44/78 316/887 
Age (years old) 42-81 30-88 
Positive history of blood trans- 29(7/22) 32(8/24) 
fusion (m/F)
Discussion 
In the present study, the HBV carrier rate was higher in 
Kami-Goto-town than in other areas in Japan;" however, 
the HBV carrier rate reached a peak in inhabitants born 
during 1941-45, and thereafter decreased. Similar results 
were reported by Matsuo'°' who demonstrated that the 
prevalence of the HBV carriers in Tomie-town in the Goto 
Islands reached a peak during 1940s and thereafter de-
creased. It remains unclear why the HBV carrier rate 
relatively decreased in inhabitants born in 1946 and after in 
Kami-Goto-town, but the redution in occurrence of hori-
zontal transmission of HBV in infancy possibly plays a 
major role as previously reported in Tomie-town. 1 I
 The positivity rate for anti-HCV in Kami-Goto-town was 
7.2%, even when the anti-HCV-positive inhabitants receiv-
ing blood transfusion were excluded. Since Nishioka9' 
demonstrated that the positivity rate for anti-HCV using 1st 
generation anti-HCV kit in Japanese blood donors was 
1.15%, Kami-Goto-town-seemed to be a very prevalent 
area for HCV infection. When the age distribution of the 
anti-HCV-positive inhabitants were analyzed by year of 
birth, more than 7% of inhabitants born in 1935 and before 
but none of inhabitants born in 1951 and after were anti-
HCV-positive. These results indicate that the positivity rate 
for anti-HCV in this area is, at present, very high, but will 
be rebuced with the advance of years. The number of 
patients with HCV-associated hepatocellular carcinoma 
was found to increase in the last 6 years in Nagasaki 
Prefecture."' However, it is possible that the incidence of 
HCV-associated hepatocellular carcinoma will decrease in 
near future, if the positivity rate for anti-HCV in inhabitants 
born in 1950s and after in Nagasaki Prefecture is as low as 
that in Kami- Goto-town. 
  The mode of HCV trasmission is still unknown. Blood 
transfusion is one of the factors in HCV transmission;", "I 
however, only 23.8% of the anti-HCV-positive inhabitants 
received blood transfusion in this study. Although several 
groups indicated familial clustering of HCV infection,",") it 
is unlikely because none of inhabitants born in 1951 and 
after from anti-HCV-positive parents were nati-HCV posi-
tive. 
  In summary, this study shows the decreased positivity 
rates for both of HBsAg and anti-HCV in inhabitants born 
in 1950s and after in Kami-Goto-town, Nagasaki Prefec-
ture, Japan.
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